» Articles » PMID: 28941610

Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia

Overview
Journal Can J Cardiol
Publisher Elsevier
Date 2017 Sep 25
PMID 28941610
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial hypercholesterolemia (FH) is a monogenic disease associated with elevated low-density lipoprotein (LDL) cholesterol and oxidized LDL (oxLDL) leading to premature cardiovascular disease. Lectin-like oxLDL receptor-1 (LOX1) is one of the major contributors of oxLDL uptake and degradation in macrophages, which leads to foam cell formation and the development of atherosclerosis. This study investigated the effect of the rs11053646 genotype of the oxidized low-density lipoprotein receptor 1 (OLR1) gene on coronary artery disease (CAD) risk in a cohort of FH patients.

Methods: A total of 665 genetically confirmed heterozygous adult patients with FH were included in the analysis. We evaluated the association between the rs11053646 genotype (GG vs GC) and CAD.

Results: The GC genotype (K167N carriers) represented 12.9% of the study cohort (n = 86), whereas 87.1% of the participants were noncarriers (GG genotype) (n = 579). A significantly higher proportion of GC carriers experienced a CAD event (40.7%) than did GG carriers (29.0%; P = 0.03). The presence of a C allele remained significantly associated with an increased CAD risk, even when the regression model was corrected for all traditional CAD risk factors (odds ratio, 3.05; 95% confidence interval, 1.63-5.70; P = 0.0005). The negative impact of carrying the C allele on CAD risk was similar in both sexes but was significantly more important in smokers as well as in younger patients with FH.

Conclusions: Carrying the C allele of the rs11053646 variant of the OLR1 gene was associated with an increased risk of CAD in heterozygous adult patients with FH, and this risk could be even greater in smokers as well as in younger patients.

Citing Articles

Apolipoprotein E E3/E4 genotype is associated with an increased risk of premature coronary artery disease.

Li Y, Zhong W, Huang C, Peng J, Li H BMC Cardiovasc Disord. 2024; 24(1):353.

PMID: 38987708 PMC: 11234594. DOI: 10.1186/s12872-024-04021-8.


Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions.

Juhasz L, Lorincz H, Szentpeteri A, Toth N, Varga E, Paragh G Int J Mol Sci. 2023; 24(20).

PMID: 37894988 PMC: 10607113. DOI: 10.3390/ijms242015308.


Associations of CKIP-1 and LOX-1 polymorphisms with the risk of type 2 diabetes mellitus with hypertension among Chinese adults.

Xiong J, Zhang L, Chen G, Dong P, Tong J, Hua L Acta Diabetol. 2023; 61(1):43-52.

PMID: 37668684 DOI: 10.1007/s00592-023-02175-z.


Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients.

Sheikh M Cardiovasc J Afr. 2022; 34(2):104-108.

PMID: 36218037 PMC: 10512050. DOI: 10.5830/CVJA-2022-038.


Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease.

Sheikh M Balkan Med J. 2021; 38(1):13-22.

PMID: 33593717 PMC: 8909218. DOI: 10.5152/balkanmedj.2021.20243.